Profile picture

Doctor Sven Van Laer

Antwerp University Hospital, Edegem (Belgium)
Membership: ESC Professional Member ACVC Member EHRA Member
Follow
Logo ESC

Contributor content

The effect of high-flow and low-flow conditions on left atrial thrombotic risk: a porcine model of mitral valve regurgitation and lone atrial fibrillation
Presentation
The effect of high-flow and low-flow conditions on left atrial thrombotic risk: a porcine model of mitral valve regurgitation and lone atrial fibrillation
Read more
Legionella prosthetic valve endocarditis after tropical holiday
Presentation
Legionella prosthetic valve endocarditis after tropical holiday
Read more
Solving global health in 30 minutes: an AI hackathon - Team 'The GEECGs'
Presentation
Solving global health in 30 minutes: an AI hackathon - Team 'The GEECGs'
Read more
The effect of tachypacing induced atrial fibrillation on atrial thrombotic biomarkers in a porcine model
Presentation
The effect of tachypacing induced atrial fibrillation on atrial thrombotic biomarkers in a porcine model
Read more
The effect of short-term mitral valve regurgitation on atrial remodelling and atrial fibrillation inducibility in an experimental porcine model
Presentation
The effect of short-term mitral valve regurgitation on atrial remodelling and atrial fibrillation inducibility in an experimental porcine model
Read more
ST-elevation myocardial infarction due to coronary embolism
Presentation
ST-elevation myocardial infarction due to coronary embolism
Read more
Bedside acetone breath analysis in differentiating acute heart failure from acute respiratory failure: an observational study in the emergency department
Presentation
Bedside acetone breath analysis in differentiating acute heart failure from acute respiratory failure: an observational study in the emergency department
Read more
Mitral regurgitation attenuates thrombotic risk in nonrheumatic atrial fibrillation: a new CHA2DS2-VASc score risk modifier?
Presentation
Mitral regurgitation attenuates thrombotic risk in nonrheumatic atrial fibrillation: a new CHA2DS2-VASc score risk modifier?
Read more

ESC 365 is supported by

novartis Explore sponsored resources